Linked Life Data

15580796

Source:http://linkedlifedata.com/resource/pubmed/id/15580796

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2004-12-7
pubmed:abstractText
Lyme disease is a tick-borne spirochetal disease that is common in Rhode Island. The OSP A based vaccine against Lyme disease that has been shown effective in animal models has now been tested by two manufacturers in thousands of people. The vaccines appear to be safe and effective. When the vaccines become available to physicians, there should be strong demand in Rhode Island, especially in the southern part of the state where there is a high degree of public awareness and experience with Lyme disease. Studies of tick populations support surveillance data that show a concentration of risk in Washington County with a trend of expansion inland. Patients who receive the vaccine should be alerted to the likelihood of local reaction and the less likely systemic effects. Additional patient education should include awareness of other tick-borne diseases such as babesiosis, chrlichiosis, and Rocky Mountain Spotted Fever that are not vaccine-preventable. Serologic testing for Lyme disease will be affected by the immune response to the vaccine. These vaccines have not yet been tested in children.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1086-5462
pubmed:author
pubmed:issnType
Print
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
373-5
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Preview: Lyme disease vaccines.
pubmed:affiliation
Office of Communicable Diseases, Rhode Island Department of Health, USA.
pubmed:publicationType
Journal Article